On solid-phase antibody assays

Octavio E. Pajaro, James F. George

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

There is considerable evidence that pre-operative and post-operative anti-human leukocyte antigen (anti-HLA) antibodies are deleterious in thoracic transplantation. While debate continues in heart and lung transplantation on the role of and the diagnosis and treatment of antibody-mediated rejection (AMR), central to the discussion is our ability to detect anti-HLA antibodies. This perspective outlines the concerns elicited by new technology for detection of anti-HLA antibodies using solid-phase assays, and highlights the need for functional assays to further understand the clinical significance of these antibodies.

Original languageEnglish (US)
Pages (from-to)1207-1209
Number of pages3
JournalJournal of Heart and Lung Transplantation
Volume29
Issue number11
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

HLA Antigens
Antibodies
Heart-Lung Transplantation
Thorax
Transplantation
Technology

Keywords

  • anti-HLA antibody
  • antibody-mediated rejection
  • panel reactive antibodies
  • solid-phase assays
  • virtual crossmatch

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

On solid-phase antibody assays. / Pajaro, Octavio E.; George, James F.

In: Journal of Heart and Lung Transplantation, Vol. 29, No. 11, 11.2010, p. 1207-1209.

Research output: Contribution to journalArticle

Pajaro, Octavio E. ; George, James F. / On solid-phase antibody assays. In: Journal of Heart and Lung Transplantation. 2010 ; Vol. 29, No. 11. pp. 1207-1209.
@article{2446739db6fa4ab1accd1662cae567c5,
title = "On solid-phase antibody assays",
abstract = "There is considerable evidence that pre-operative and post-operative anti-human leukocyte antigen (anti-HLA) antibodies are deleterious in thoracic transplantation. While debate continues in heart and lung transplantation on the role of and the diagnosis and treatment of antibody-mediated rejection (AMR), central to the discussion is our ability to detect anti-HLA antibodies. This perspective outlines the concerns elicited by new technology for detection of anti-HLA antibodies using solid-phase assays, and highlights the need for functional assays to further understand the clinical significance of these antibodies.",
keywords = "anti-HLA antibody, antibody-mediated rejection, panel reactive antibodies, solid-phase assays, virtual crossmatch",
author = "Pajaro, {Octavio E.} and George, {James F.}",
year = "2010",
month = "11",
doi = "10.1016/j.healun.2010.06.016",
language = "English (US)",
volume = "29",
pages = "1207--1209",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - On solid-phase antibody assays

AU - Pajaro, Octavio E.

AU - George, James F.

PY - 2010/11

Y1 - 2010/11

N2 - There is considerable evidence that pre-operative and post-operative anti-human leukocyte antigen (anti-HLA) antibodies are deleterious in thoracic transplantation. While debate continues in heart and lung transplantation on the role of and the diagnosis and treatment of antibody-mediated rejection (AMR), central to the discussion is our ability to detect anti-HLA antibodies. This perspective outlines the concerns elicited by new technology for detection of anti-HLA antibodies using solid-phase assays, and highlights the need for functional assays to further understand the clinical significance of these antibodies.

AB - There is considerable evidence that pre-operative and post-operative anti-human leukocyte antigen (anti-HLA) antibodies are deleterious in thoracic transplantation. While debate continues in heart and lung transplantation on the role of and the diagnosis and treatment of antibody-mediated rejection (AMR), central to the discussion is our ability to detect anti-HLA antibodies. This perspective outlines the concerns elicited by new technology for detection of anti-HLA antibodies using solid-phase assays, and highlights the need for functional assays to further understand the clinical significance of these antibodies.

KW - anti-HLA antibody

KW - antibody-mediated rejection

KW - panel reactive antibodies

KW - solid-phase assays

KW - virtual crossmatch

UR - http://www.scopus.com/inward/record.url?scp=78049278741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049278741&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2010.06.016

DO - 10.1016/j.healun.2010.06.016

M3 - Article

C2 - 20810292

AN - SCOPUS:78049278741

VL - 29

SP - 1207

EP - 1209

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 11

ER -